Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices

Artificial Organs

Volumn 38, Issue 10, 2014, Pages 875-879

  Jennings, Douglas L ^a,b   Chopra, Anuvrat ^c   Chambers, Rachel ^d   Morgan, Jeffrey A ^d  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

Chronic antimicrobial suppression; Infection; Left ventricular assist device

Indexed keywords

ANTIBIOTICS; FIBER OPTIC SENSORS; LEFT VENTRICULAR ASSIST DEVICES; PATIENT TREATMENT;

ANTIBIOTIC TREATMENT; CHRONIC ANTIMICROBIAL SUPPRESSION; CLINICAL OUTCOME; COHORT STUDIES; CONTINUOUS-FLOW; DRIVELINES; HEART TRANSPLANTATION; INFECTION; INTERNATIONAL SOCIETY; LUNG TRANSPLANTATION;

MICROORGANISMS;

ANTIINFECTIVE AGENT; COTRIFAMOLE; COTRIMOXAZOLE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA; CATHETER INFECTION; CHRONIC DRUG ADMINISTRATION; COHORT ANALYSIS; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; DEVICE INFECTION; DIARRHEA; DRIVELINE INFECTION; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; GASTROINTESTINAL TOXICITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; OUTCOME ASSESSMENT; PEPTOCLOSTRIDIUM DIFFICILE; RETROSPECTIVE STUDY; SKIN MANIFESTATION; VOMITING; ADVERSE EFFECTS; HEART ASSIST DEVICE; HEART FAILURE; MICROBIOLOGY; PROSTHESIS-RELATED INFECTIONS; SECONDARY PREVENTION; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; COHORT STUDIES; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84916233448     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12254     Document Type: Article

References (15)

1. John R, Kamdar F, Liao K, etal. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge to transplant therapy. Ann Thorac Surg 2008;86:1227-1235.
2. Kirklin JK, Naftel DC, Kormos RL, etal. Fifth INTERMACS annual report: risk factor analysis from more than 6000 mechanical circulatory support patients. J Heart Lung Transplant 2013;32:141-156.
3. Topkara VK, Kondareddy S, Malik F, etal. Infectious complications in patients with left ventricular device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010;90:1270-1277.
4. Hasin T, Marmor Y, Kremers W. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol 2013;61:153-163.
5. Schaffer JM, Allen JG, Weiss ES, etal. Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. J Heart Lung Transplant 2011;30:164-174.
6. Slaughter MS, Pagani FD, Rogers JG, etal. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010;29:S1-39.
7. Nienaber JJ, Kusne S, Riaz T, etal. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis 2013;57:1438-1448.
8. Feldman D, Pamboukian SV, Teuteberg JJ, etal. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013;32:157-187.
9. Hannan MM, Husain S, Mattner F, etal. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 2011;30:375-384.
10. Goldstein DJ, Naftel D, Holman W, etal. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant 2012;31:1151-1157.
11. Gordon RJ, Weinberg AD, Pagani FD, etal. Prospective, multicenter study of ventricular assist device infections. Circulation 2013;127:691-702.
12. Tsukui H, Abla A, Teuteberg JJ, etal. Cerebrovascular accidents in patients with a ventricular assist device. J Thorac Cardiovasc Surg 2007;134:114-123.
13. Moazami N, Milano CA, John R, etal. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg 2013;95:500-505.
14. Sharma V, Deo SV, Stulak JM, etal. Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg 2012;94:1381-1386.
15. Chamogeorgakis T, Koval CE, Smedira NG, etal. Outcomes associated with surgical management of infections related to the HeartMate II left ventricular assist device: implications for destination therapy. J Heart Lung Transplant 2012;31:904-906.